Skip to main content

Down’s Risk Screening (DRP)

Monday 23 May 2022

The antenatal screening service carried out by the Wolfson Institute is being discontinued in June 2022 and all samples for Down’s Risk Screening (first or second trimester) will be referred to the specialist service at Addenbrooke’s Hospital from 23rd May 2022.

Multiplex (HIV / Hep B / Hep C PCR Early) Detection Screening

Monday 23 May 2022

TDL test code STDX is now being processed as an in-house assay. There is no change to methodology (NAAT) or sample requirement. TAT remains unchanged.

Esoteric referred tests

Monday 23 May 2022

Following a review of the contracts with referral laboratories, we have identified two laboratories that whilst being ‘GDPR Compliant’, do not follow the typical data model.

Allergy testing: The ALEX2 test

Monday 23 May 2022

The ALEX2 test allows for IgE multiplexing of c300 allergens (extracts and molecular allergens) from
a small volume serum sample.

T cells: T-SPOT COVID test

Monday 23 May 2022

The T-SPOT®.COVID test, for qualitative detection of a cell mediated (T cell) immune response to SARS CoV-2 in whole blood, now includes detection of immune response after vaccine.

Microbiology: Culture for Mycoplasma, Ureaplasma and Trichomonas vaginalis

Monday 23 May 2022

Culture for Mycoplasma, Ureaplasma and Trichomonas vaginalis has been replaced by more sensitive and specific targeted PCR testing.